News

GHK-Cu is a copper-binding peptide investigated for protective effects in COPD and lung fibrosis research. Experimental findings demonstrate modulation of inflammatory signaling, oxidative stress responses, and extracellular matrix remodeling pathways. In vitro and in vivo studies indicate reduced inflammatory injury, improved tissue repair, and regulated fibrotic signaling, providing mechanistic insight into potential pulmonary tissue protection and regenerative respiratory biology.

This mechanistic review evaluates how impaired NAD+ homeostasis contributes to mitochondrial disease pathogenesis. It examines disrupted redox balance, oxidative phosphorylation defects, and excessive NAD+ consumption across mitochondrial dysfunction models. Moreover, the regulatory roles of sirtuins, PARPs, and CD38 are critically analyzed. Consequently, the article integrates preclinical evidence linking NAD+ depletion with mitochondrial bioenergetic instability and progressive cellular dysfunction.

This research-focused blog evaluates tendon healing responses to BPC-157 and TB-500 in rodent models, examining collagen remodeling, fibroblast activity, angiogenesis, biomechanical strength, pharmacokinetics, and translational limitations. It highlights gaps in long-term fibrosis surveillance and dose-response data while emphasizing the need for structured preclinical studies to define safety thresholds and optimize tendon regeneration research frameworks.

Melanotan II plays a significant role in appetite research by activating melanocortin receptors that regulate hunger and satiety. It influences neural pathways, reduces food intake, and supports energy balance studies, making it valuable for understanding metabolic processes and obesity-related mechanisms in controlled research settings.

This research-based article examines how MOTS-C regulates AMPK activity during cellular energy stress. It highlights mitochondrial-nuclear signaling, AMPK phosphorylation, metabolic adaptation, and insulin sensitivity. Evidence from preclinical models demonstrates how MOTS-C supports energy homeostasis, oxidative metabolism, and stress-responsive recovery without inducing chronic metabolic overstimulation

Tesamorelin is a stabilized GHRH analog widely studied for its ability to modulate endocrine dynamics within the GH–IGF-1 axis. This article compares tesamorelin with native GHRH by analyzing receptor signaling, feedback regulation, and systemic endocrine crosstalk. Evidence from clinical and translational studies is presented with a focus on mechanistic insights, pulsatility patterns, and experimental relevance.